Invesco Rising Dividends Fund Q4 2025 Commentary [Seeking Alpha]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Seeking Alpha
Still, strong corporate earnings and US Federal Reserve (Fed) rate cuts helped stocks finish the quarter with gains. Value stocks outperformed growth, supported by resilient sectors like health care and communication services. The fund's focus on companies with sustainable free cash flow and healthy balance sheets provided defensive qualities. Notable portfolio additions included resilient, innovation-driven businesses benefiting from secular growth trends. Sales reflected cautious risk management amid concern about elevated spending and valuation pressures in certain technology and industrial stocks. Pla2na/iStock via Getty Images Investment objective The fund seeks total return. Click to enlarge Fund facts Fund AUM ($M) Click to enlarge Portfolio managers Raman Vardharaj, Peter Santoro, Belinda Cavazos Click to enlarge Manager perspective This article was written by Quick Insights The fund emphasizes companies with sustainable free cash flow and he
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- How The Story On Abbott Laboratories (ABT) Is Shifting As Analysts Rework Targets And Risks [Yahoo! Finance]Yahoo! Finance
- Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management [Yahoo! Finance]Yahoo! Finance
- Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose managementPR Newswire
- Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks [Yahoo! Finance]Yahoo! Finance
- Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose managementPR Newswire
ABT
Earnings
- 1/22/26 - In-Line
ABT
Sec Filings
- 3/13/26 - Form ARS
- 3/13/26 - Form DEF
- 3/13/26 - Form DEFA14A
- ABT's page on the SEC website